Welcome to our dedicated page for Walgreen Boots SEC filings (Ticker: WBA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page aggregates U.S. Securities and Exchange Commission filings for Walgreens Boots Alliance, Inc. (historically Nasdaq: WBA) and related securities, with AI-powered tools to help interpret the regulatory record. These documents trace the company’s transition from a publicly traded integrated healthcare, pharmacy and retail group to a privately held subsidiary of Blazing Star Parent, LLC, an affiliate of Sycamore Partners.
Among the most significant filings is the Form 8-K dated August 28, 2025, which reports the completion of the merger of Blazing Star Merger Sub, Inc. with and into Walgreens Boots Alliance, Inc. This filing explains that each share of company common stock was converted into the right to receive cash consideration and a divested asset proceed right, and that the company would become a wholly owned subsidiary of Blazing Star Parent, LLC. The same Form 8-K also describes the termination of certain credit facilities and the notice to The Nasdaq Stock Market LLC that WBA common stock and specified notes would be removed from listing.
A related Form 25, filed on August 28, 2025, documents the removal of Walgreens Boots Alliance, Inc. common stock and certain notes from listing and registration on Nasdaq. Subsequently, a Form 15 filed on September 8, 2025 certifies the termination of registration of the company’s common stock and various series of notes under Section 12(g) of the Securities Exchange Act of 1934 and the suspension of the duty to file reports under Sections 13 and 15(d). Together, these filings confirm WBA’s delisting and deregistration following the merger.
Earlier Form 8-K filings provide additional context on the transaction and corporate actions. These include disclosures about the Agreement and Plan of Merger with Blazing Star Parent, LLC and Blazing Star Merger Sub, Inc., the special meeting of stockholders held to vote on the merger agreement, the temporary suspension of trading under employee benefit plans in connection with the transaction, and supplemental proxy statement disclosures addressing shareholder litigation and demand letters related to the merger. Another Form 8-K furnishes a press release announcing financial results for the fiscal quarter ended May 31, 2025.
Debt-related filings and referenced documents, including press releases by Blazing Star Merger Sub, Inc., describe tender offers and consent solicitations for multiple series of Walgreens Boots Alliance, Inc. and Walgreen Co. notes, along with pricing terms, early tender results and extensions of expiration times. These materials are relevant for understanding how the company and its acquirer managed outstanding debt securities around the time of the merger.
On this SEC filings page, users can review these historical documents in one place. AI-powered summaries highlight key terms from complex forms such as Form 8-K, Form 25 and Form 15, explain the implications of delisting and deregistration, and clarify how equity and debt holders were affected by the merger. Real-time connections to the EDGAR system ensure that filings related to WBA’s historical record are captured, while AI tools help interpret legal and financial language so that readers can more easily understand corporate actions, capital structure changes and the company’s transition from public to private ownership.
Walgreens Boots Alliance, Inc. filed a Form 15 to terminate the registration of certain securities under Section 12(g) of the Securities Exchange Act of 1934 and to suspend its duty to file ongoing reports under Sections 13 and 15(d). The filing covers the company’s common stock with a par value of $0.01 per share and multiple series of Walgreens Boots Alliance, Inc. and Walgreen Co. notes maturing between 2025 and 2050. The certification is signed on behalf of the company by Lanesha Minnix, Executive Vice President, Global Chief Legal Officer and Corporate Secretary.
Silver Point Capital and two principals filed a Schedule 13G regarding Walgreens Boots Alliance (WBA). The filing states that as of August 27, 2025 the Reporting Persons beneficially owned 60,061,000 shares, representing 6.9% of 865,560,675 shares outstanding (per the issuer's June 19, 2025 count). The issuer completed a merger on August 28, 2025 and the Reporting Persons' shares were converted into the stated Per Share Consideration. The cover pages list 0 shares beneficially owned at filing, reflecting that conversion. The Schedule is jointly filed by Silver Point Capital, L.P., Edward A. Mule and Robert J. O'Shea and includes a Joint Filing Agreement.
Senior Vice President and Chief Corporate Affairs Officer Beth Amber L. Fabbri reported a disposition of 124,670 shares of Walgreens Boots Alliance, Inc. common stock on 08/28/2025. The filing shows 0 shares beneficially owned following the reported transaction. The disposal reflects cancellation of restricted stock units (including dividend-equivalent RSUs) in connection with the merger described in the filing: at the merger's effective time each share of common stock was converted into $11.45 in cash plus one divested asset proceed right. The filing notes that consideration for any RSUs that were unvested at the effective time remains subject to continued employment-based vesting conditions.
Manmohan Mahajan, EVP and Global CFO of Walgreens Boots Alliance (WBA), reported a transaction dated 08/28/2025 disposing of 414,273 shares of WBA common stock, leaving him with 0 shares beneficially owned following the transaction. The Form 4 explains the disposition resulted from the Merger under the March 6, 2025 Merger Agreement, where each share was converted at the Effective Time into $11.45 in cash plus one Divested Asset Proceed Right. RSUs held by the reporting person were cancelled in exchange for the Per Share Consideration, although any unvested RSUs remain subject to the original vesting conditions tied to continued service.
Lanesha Minnix, EVP, Global CLO & Corporate Secretary of Walgreens Boots Alliance (WBA), reported the automatic disposition of 348,093 shares of WBA common stock on 08/28/2025 as a result of the closing of a merger. Under the Merger Agreement, each WBA share converted into $11.45 cash per share plus one divested asset proceed right. All RSUs held by the reporting person were cancelled and exchanged for the per-share consideration; payment for any unvested RSUs remains subject to the holder’s continued employment and prior vesting conditions. Following the transaction the reporting person beneficially owns 0 shares of WBA common stock.
FAQ
What is the current stock price of Walgreen Boots (WBA)?
What is the market cap of Walgreen Boots (WBA)?
